journal article·2021-05Open access

Ultraefficiently Calming Cytokine Storm Using Ti3C2Tx MXene

Tianyi Wang, Xiaoyu Sun, Xin Guo, Jinqiang Zhang, Jian Yang, Shouxuan Tao, Jun Guan, Lin Zhou, Jie Han, Chengyin Wang, Hang Yao, Guoxiu Wang

Small Methods· Volume 5· Issue 5

Abstract

Abstract During the global outbreak of COVID‐19 pandemic, “cytokine storm” conditions are regarded as the fatal step resulting in most mortality. Hemoperfusion is widely used to remove cytokines from the blood of severely ill patients to prevent uncontrolled inflammation induced by a cytokine storm. This article discoveres, for the first time, that 2D Ti3C2Tx MXene sheet demonstrates an ultrahigh removal capability for typical cytokine interleukin‐6. In particular, MXene shows a 13.4 times higher removal efficiency over traditional activated carbon absorbents. Molecular‐level investigations reveal that MXene exhibits a strong chemisorption mechanism for immobilizing cytokine interleukin‐6 molecules, which is different from activated carbon absorbents. MXene sheet also demonstrates excellent blood compatibility without any deleterious side influence on the composition of human blood. This work can open a new avenue to use MXene sheets as an ultraefficient hemoperfusion absorbent to eliminate the cytokine storm syndrome in treatment of severe COVID‐19 patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: MXene and MAX Phase Materials · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Science University of Technology Sydney Sydney NSW 2007 Australia

School of Chemistry and Chemical Engineering Yangzhou University Yangzhou Jiangsu Province 225002 P. R. China

Clinical Medical College Northern Jiangsu People's Hospital Yangzhou University Yangzhou Jiangsu Province 225009 P. R. China

Funding

Priority Academic Program Development of Jiangsu Higher Education Institutions

References (48)

Show source-provided references
1. 10.1126/science.aba975710.1126/science.aba9757 ↗
2. World Health Organization https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019 Vol.10 2019.
3. B.Zhang X.Zhou Y.Qiu F.Feng J.Feng Y.Jia H.Zhu K.Hu J.Liu Z.Liu S.Wang Y.Gong C.Zhou T.Zhu Y.Cheng Z.Liu H.Deng F.Tao Y.Ren B.Cheng L.Gao X.Wu L.Yu Z.Huang Z.Mao Q.Song B.Zhu J.Wang medRxiv 2020 2020.02.26.20028191.
4. 10.1016/S0140-6736(20)30183-510.1016/S0140-6736(20)30183-5 ↗
5. 10.1089/jir.2019.008910.1089/jir.2019.0089 ↗
6. 10.1016/j.bbamcr.2011.01.03410.1016/j.bbamcr.2011.01.034 ↗
7. 10.1089/jir.2019.008510.1089/jir.2019.0085 ↗
8. 10.1038/s41577-020-0311-810.1038/s41577-020-0311-8 ↗
9. 10.1016/j.oraloncology.2020.10465910.1016/j.oraloncology.2020.104659 ↗
10. 10.1016/j.jcv.2004.07.00610.1016/j.jcv.2004.07.006 ↗
11. 10.1002/jmv.2578810.1002/jmv.25788 ↗
12. 10.1016/S0140-6736(20)30317-210.1016/S0140-6736(20)30317-2 ↗
13. 10.1007/s00134-015-3751-z10.1007/s00134-015-3751-z ↗
14. 10.1016/j.carbpol.2018.08.06710.1016/j.carbpol.2018.08.067 ↗
15. 10.1021/nn204153h10.1021/nn204153h ↗
16. 10.1016/j.jechem.2019.06.01410.1016/j.jechem.2019.06.014 ↗
17. 10.1007/s40820-020-0411-910.1007/s40820-020-0411-9 ↗
18. 10.1126/science.aag242110.1126/science.aag2421 ↗
19. 10.1016/B978-0-323-44942-7.00163-110.1016/B978-0-323-44942-7.00163-1 ↗
20. 10.1016/S0039-6028(00)00730-510.1016/S0039-6028(00)00730-5 ↗
21. 10.1021/acsabm.8b0015110.1021/acsabm.8b00151 ↗
22. 10.1007/s10856-011-4368-610.1007/s10856-011-4368-6 ↗
23. 10.1002/advs.20200189910.1002/advs.202001899 ↗
24. 10.3390/ijms2021542610.3390/ijms20215426 ↗
25. 10.2147/IJN.S20829210.2147/IJN.S208292 ↗
26. 10.1002/cssc.20160016510.1002/cssc.201600165 ↗
27. 10.1038/s41598-020-69947-310.1038/s41598-020-69947-3 ↗
28. 10.1039/B102780H10.1039/B102780H ↗
29. 10.1016/0022-2836(88)90471-810.1016/0022-2836(88)90471-8 ↗
30. 10.1038/nprot.2015.02410.1038/nprot.2015.024 ↗
31. 10.1111/j.1745-7270.2007.00320.x10.1111/j.1745-7270.2007.00320.x ↗
32. 10.1016/0022-2860(95)09117-310.1016/0022-2860(95)09117-3 ↗
33. 10.1039/C5RA03984C10.1039/C5RA03984C ↗
34. 10.1002/pro.556003121310.1002/pro.5560031213 ↗
35. 10.1038/nprot.2006.20210.1038/nprot.2006.202 ↗
36. 10.1111/j.1432-1033.1995.tb20427.x10.1111/j.1432-1033.1995.tb20427.x ↗
37. 10.1021/cr100440g10.1021/cr100440g ↗
38. 10.1038/s41598-019-52495-w10.1038/s41598-019-52495-w ↗
39. 10.1038/s41598-017-09749-210.1038/s41598-017-09749-2 ↗
40. Schein C. H. · BioTech · 1990 · 8 · 308
41. 10.1016/S0008-6223(98)00135-310.1016/S0008-6223(98)00135-3 ↗
42. 10.1039/C8TB02504E10.1039/C8TB02504E ↗
43. 10.1016/j.actbio.2020.05.01610.1016/j.actbio.2020.05.016 ↗
44. 10.1111/j.0954-6820.1966.tb02875.x10.1111/j.0954-6820.1966.tb02875.x ↗
45. 10.1111/sdi.1224610.1111/sdi.12246 ↗
46. Howell C. A. · Eurosurveillance · 2020 · 25 · 10
47. 10.1002/adfm.20200084110.1002/adfm.202000841 ↗
48. 10.1016/j.clineuro.2020.10606610.1016/j.clineuro.2020.106066 ↗